Patterns of Immunohistochemical Expression of P53, BCL2, PTEN, and HER2/neu Tumor Markers in Specific Breast Cancer Lesions

Table 2

Distribution of the study population by sex and pathology.

Lesion type	Females	Males	Total
Benign lesions	104	0	104
Carcinoma SBR	1	0	1
Infiltrating DC	44	3	47
Invasive DC	133	0	133
Residual intraductal (RIDC)	2	0	2
Intracystic CA	1	0	1
Ductal carcinoma in situ	3	0	3
MDFC	1	1	2
Poorly differentiated carcinoma (PDFC)	2	0	2
Malignant adnexal neoplasm skin (MANS)	0	1	1
Metastatic DA	2	0	2
Invasive LC	7	1	8
Total	300	6	306